GOCOVRI
Zydus Lifesciences gets USFDA nod for generic medicationZydus Lifesciences has received approval from the USFDA to market Amantadine extended-release capsules (68.5 mg) and tentative approval for...
Jefferies upgrades Zydus Life to 'Buy' on strong US pipeline potential, stock up 4%Global brokerage firm Jefferies has upgraded Zydus Lifesciences to a 'Buy' rating, citing the strength of the company’s US pipeline as a ma...
- Load More